These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 18220729)

  • 61. Leukocyte and cardiac phosphoinositide 3-kinase γ activity in pressure overload-induced cardiac failure.
    Perino A; Ghigo A; Hirsch E
    Trends Cardiovasc Med; 2010 Nov; 20(8):273-6. PubMed ID: 22433654
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Role of phospholamban in regulating cardiac sarcoplasmic reticulum calcium pump.
    Ambudkar IS; Shamoo AE
    Membr Biochem; 1984; 5(2):119-30. PubMed ID: 6143239
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular determinants of PI3Kγ-mediated activation downstream of G-protein-coupled receptors (GPCRs).
    Vadas O; Dbouk HA; Shymanets A; Perisic O; Burke JE; Abi Saab WF; Khalil BD; Harteneck C; Bresnick AR; Nürnberg B; Backer JM; Williams RL
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18862-7. PubMed ID: 24190998
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases.
    Rathinaswamy MK; Fleming KD; Dalwadi U; Pardon E; Harris NJ; Yip CK; Steyaert J; Burke JE
    Structure; 2021 Dec; 29(12):1371-1381.e6. PubMed ID: 34348129
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Twice upon a time: PI3K's secret double life exposed.
    Hirsch E; Braccini L; Ciraolo E; Morello F; Perino A
    Trends Biochem Sci; 2009 May; 34(5):244-8. PubMed ID: 19376709
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Assigning functional domains within the p101 regulatory subunit of phosphoinositide 3-kinase gamma.
    Voigt P; Brock C; Nürnberg B; Schaefer M
    J Biol Chem; 2005 Feb; 280(6):5121-7. PubMed ID: 15611065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Specific PI3K isoform modulation in heart failure: lessons from transgenic mice.
    Ghigo A; Morello F; Perino A; Damilano F; Hirsch E
    Curr Heart Fail Rep; 2011 Sep; 8(3):168-75. PubMed ID: 21519914
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiovascular toxicity of PI3Kα inhibitors.
    Sadasivan C; Zhabyeyev P; Labib D; White JA; Paterson DI; Oudit GY
    Clin Sci (Lond); 2020 Oct; 134(19):2595-2622. PubMed ID: 33063821
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Compartmentalized cAMP/PKA signalling regulates cardiac excitation-contraction coupling.
    Lissandron V; Zaccolo M
    J Muscle Res Cell Motil; 2006; 27(5-7):399-403. PubMed ID: 16902751
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular basis for differential activation of p101 and p84 complexes of PI3Kγ by Ras and GPCRs.
    Rathinaswamy MK; Jenkins ML; Duewell BR; Zhang X; Harris NJ; Evans JT; Stariha JTB; Dalwadi U; Fleming KD; Ranga-Prasad H; Yip CK; Williams RL; Hansen SD; Burke JE
    Cell Rep; 2023 Mar; 42(3):112172. PubMed ID: 36842083
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure of the phosphoinositide 3-kinase (PI3K) p110γ-p101 complex reveals molecular mechanism of GPCR activation.
    Rathinaswamy MK; Dalwadi U; Fleming KD; Adams C; Stariha JTB; Pardon E; Baek M; Vadas O; DiMaio F; Steyaert J; Hansen SD; Yip CK; Burke JE
    Sci Adv; 2021 Aug; 7(35):. PubMed ID: 34452907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The SLMAP/Striatin complex: An emerging regulator of normal and abnormal cardiac excitation-contraction coupling.
    Nader M
    Eur J Pharmacol; 2019 Sep; 858():172491. PubMed ID: 31233748
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain.
    Harris NJ; Jenkins ML; Nam SE; Rathinaswamy MK; Parson MAH; Ranga-Prasad H; Dalwadi U; Moeller BE; Sheeky E; Hansen SD; Yip CK; Burke JE
    Elife; 2023 Jul; 12():. PubMed ID: 37417733
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Allosteric activation or inhibition of PI3Kγ mediated through conformational changes in the p110γ helical domain.
    Harris NJ; Jenkins ML; Nam SE; Rathinaswamy MK; Parson MA; Ranga-Prasad H; Dalwadi U; Moeller BE; Sheekey E; Hansen SD; Yip CK; Burke JE
    bioRxiv; 2023 May; ():. PubMed ID: 37090531
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discovery of a Novel Series of Potent and Selective Alkynylthiazole-Derived PI3Kγ Inhibitors.
    Bandarage UK; Aronov AM; Cao J; Come JH; Cottrell KM; Davies RJ; Giroux S; Jacobs M; Mahajan S; Messersmith D; Moody CS; Swett R; Xu J
    ACS Med Chem Lett; 2021 Jan; 12(1):129-135. PubMed ID: 33488974
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The potential roles of exosomes in pathological cardiomyocyte hypertrophy mechanisms and therapy: A review.
    Zhang L; Xie F; Zhang F; Lu B
    Medicine (Baltimore); 2024 Apr; 103(17):e37994. PubMed ID: 38669371
    [TBL] [Abstract][Full Text] [Related]  

  • 77. PI3K as Mediator of Apoptosis and Contractile Dysfunction in TGFβ
    Brosinsky P; Bornbaum J; Warga B; Schulz L; Schlüter KD; Ghigo A; Hirsch E; Schulz R; Euler G; Heger J
    Biology (Basel); 2021 Jul; 10(7):. PubMed ID: 34356525
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systems Pharmacological Approach to the Effect of
    Suh SY; An WG
    Evid Based Complement Alternat Med; 2017; 2017():7236436. PubMed ID: 29234425
    [No Abstract]   [Full Text] [Related]  

  • 79. Scaffolding Function of PI3Kgamma Emerges from Enzyme's Shadow.
    Mohan ML; Naga Prasad SV
    J Mol Biol; 2017 Mar; 429(6):763-772. PubMed ID: 28179187
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Possible Biomarkers for the Early Detection of HIV-associated Heart Diseases: A Proteomics and Bioinformatics Prediction.
    Rasheed S; Hashim R; Yan JS
    Comput Struct Biotechnol J; 2015; 13():145-52. PubMed ID: 25750702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.